Streetbeat News

Products Services

CVNA

Carvana shares are trading higher after the company announced the launch of same day delivery in Newark, New Jersey.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 3:42 pm

BTTR

BX

KKR

LLY

NVO

The success of weight loss drugs for humans, such as Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Zepbound, could potentially extend to the pet market. Companies like Okava Pharmaceuticals and Vivani Medical are developing weight loss drugs for pets, while Better Choice Company has acquired Aimia Pet Healthco to develop GLP-1 drugs. Despite skepticism from veterinary experts, the pet industry is projected to grow, and the introduction of such drugs could replicate the success seen in the human market.

Portfolio Pulse from Hayden Buckfire

June 12, 2024 | 3:42 pm

VKTX

Deep-pocketed investors have shown unusual bearish options activity for Viking Therapeutics (NASDAQ:VKTX), with 66% of the trades being bearish. This significant move suggests potential upcoming volatility for VKTX. The stock is currently trading at $53.48, up by 1.42%, with the next earnings report due in 42 days.

Portfolio Pulse from Benzinga Insights

June 12, 2024 | 3:32 pm

BIIB

LLY

At the Goldman Sachs Conference, a Biogen executive stated that the Alzheimer's drug market will develop faster with Eli Lilly's involvement. However, the executive refrained from speculating on the future of Donanemab's label.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 3:30 pm

NVO

Michigan's largest insurer has decided to stop covering weight-loss drugs, which could impact pharmaceutical companies that produce these medications.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 3:29 pm

BIIB

LLY

Biogen's executive expressed confidence in the success of their Alzheimer's drug, LEQEMBI, regardless of competition. The executive also mentioned that Eli Lilly's experimental Alzheimer's drug will help grow the market. This was stated at the Goldman Sachs Conference.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 3:28 pm

RWGI

Rodedawg International Industries, Inc. (OTC:RWGI) has launched a TikTok Shop to leverage the platform's e-commerce potential, aiming to expand its market reach and increase sales of its product lines, starting with the Elixicure Topical Pain Relief cream.

Portfolio Pulse from Jelena Martinovic

June 12, 2024 | 3:20 pm

AAPL

ARKK

ARKQ

ARKW

MSFT

TSLA

Cathie Wood and Ark Invest have set a new price target of $2,600 for Tesla by 2029, driven by the company's autonomous vehicle ambitions. The forecast heavily relies on Tesla's robotaxi business, predicting significant revenue and EBITDA contributions from this segment. Tesla's potential market capitalization could reach up to $10.9 trillion in a bull case scenario.

Portfolio Pulse from Chris Katje

June 12, 2024 | 3:18 pm

AAPL

AMZN

GLD

GOOG

META

MSFT

NVDA

QQQ

SLV

SPY

TSLA

USO

The stock market is reacting positively to cooler-than-expected CPI data, with significant buying in AI stocks and major tech companies. The probability of a rate cut by the Fed in September is now 55%, and 90% by December. Inflation in China is also falling, which helps lower U.S. inflation. The International Energy Agency predicts an oil surplus by 2030. Bitcoin is rallying on lower CPI. Investors are advised to maintain a balanced protection band to manage risk.

Portfolio Pulse from The Arora Report

June 12, 2024 | 3:18 pm

RNA

Avidity Biosciences (NASDAQ:RNA) shares surged 33.5% following positive results from the Phase 1/2 FORTITUDE trial for treating facioscapulohumeral muscular dystrophy (FSHD) with delpacibart braxlosiran. The trial showed significant functional improvements and good tolerance, offering hope for FSHD patients.

Portfolio Pulse from Dylan Berman

June 12, 2024 | 3:15 pm